# Device Evaluation of Contak Renewal 2and Easytrak 2 - DECREASE-HF

> **NCT00158951** · PHASE2,PHASE3 · COMPLETED · sponsor: **Boston Scientific Corporation** · enrollment: 360 (—)

## Conditions studied

- Congestive Heart Failure

## Interventions

- **DEVICE:** CONTAK RENEWAL 2/4/4HE CRT-D
- **DEVICE:** EASYTRAK 2 Lead

## Key facts

- **NCT ID:** NCT00158951
- **Lead sponsor:** Boston Scientific Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-03
- **Primary completion:** —
- **Final completion:** 2004-10
- **Target enrollment:** 360 (—)
- **Last updated:** 2007-06-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00158951

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00158951, "Device Evaluation of Contak Renewal 2and Easytrak 2 - DECREASE-HF". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT00158951. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*